{"id":61868,"title":"Ibrutinib inhibits BCR and NF-?B signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL.","abstract":"","date":"2014-05-23","categories":"Hemic and Lymphatic Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24659631","annotations":[{"name":"Cell (biology)","weight":0.804197,"wikipedia_article":"http://en.wikipedia.org/wiki/Cell_(biology)"},{"name":"Tumor","weight":0.605737,"wikipedia_article":"http://en.wikipedia.org/wiki/Tumor"},{"name":"Cell growth","weight":0.539073,"wikipedia_article":"http://en.wikipedia.org/wiki/Cell_growth"},{"name":"Enzyme inhibitor","weight":0.282633,"wikipedia_article":"http://en.wikipedia.org/wiki/Enzyme_inhibitor"},{"name":"Cell signaling","weight":0.213361,"wikipedia_article":"http://en.wikipedia.org/wiki/Cell_signaling"},{"name":"BCR gene","weight":0.0539958,"wikipedia_article":"http://en.wikipedia.org/wiki/BCR_gene"},{"name":"B-cell chronic lymphocytic leukemia","weight":0.035931,"wikipedia_article":"http://en.wikipedia.org/wiki/B-cell_chronic_lymphocytic_leukemia"},{"name":"National Film Board of Canada","weight":0.0152478,"wikipedia_article":"http://en.wikipedia.org/wiki/National_Film_Board_of_Canada"}]}
